Atrial natriuretic peptide release is stimulated by increased atrial pressure and right atrial distension, and is regulated by cytosolic calcium, the phosphoinositide system, and the cyclic AMP pathway.
This review highlights that atrial stretch and intracellular signaling pathways (calcium, cAMP) are the primary mechanisms driving the secretion of atrial natriuretic peptide.
Mammalian atrial cardiocytes synthesize and secrete a hormone called atrial natriuretic peptide (ANP), which causes natriuresis, diuresis and inhibition of smooth muscle contraction, aldosterone and renin release. Volume loading, vasoconstrictor agents, immersion in water, atrial tachycardia and high salt diets have been reported to increase the release of cardiac ANP, thereby suggesting that the peptide is released in response to an increase in atrial pressure. That stretch is an important stimulus for ANP release is also suggested by clinical studies demonstrating a direct correlation between secretion rate and atrial pressure. The experiments using isolated perfused rat heart provide direct evidence that distension of the right atrium stimulates the release of ANP. Pharmacological studies in the isolated heart point to roles of cytosolic calcium, the phosphoinositide system and the cyclic AMP pathway in the regulation of ANP release. The concentration of calcium in heart muscle cells, in addition to the length of the muscle fibers, depends on many factors such as the action of humoral substances, cardiac nerve activity and heart rate, which may all contribute to the regulation of ANP secretion.
Ruskoaho et al. (Sat,) reported a review. Atrial natriuretic peptide release is stimulated by increased atrial pressure and right atrial distension, and is regulated by cytosolic calcium, the phosphoinositide system, and the cyclic AMP pathway.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: